ScholarIQanswers from OpenAlex
RNA modifications and cancer
TopicLeading institutions, researchers & key papers
RNA modifications and cancer is a topic indexed in ScholarIQ from OpenAlex.
What is known about RNA modifications and cancer?
ScholarIQrecord summary
This cluster of papers explores the diverse landscape of RNA methylation, with a focus on m6A modification, its impact on gene expression, ribosome biogenesis, and its role in cancer progression. The research covers various aspects such as m6A-seq, tRNA fragments, YTHDF proteins, and the involvement of methyltransferases in mRNA modification.
How many works does RNA modifications and cancer have?
ScholarIQindexed works
RNA modifications and cancer has 672 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for RNA modifications and cancer?
ScholarIQopenalex
The OpenAlex for RNA modifications and cancer is on the source record.
What are the most-cited papers on RNA modifications and cancer?
ScholarIQmost cited works
A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
Anna Helgadóttir, Guðmar Þorleifsson, Andrei Manolescu, Sólveig Grétarsdóttir, Thórarinn Blöndal, Áslaug Jónasdóttir, Aðalbjörg Jónasdóttir, Ásgeir Sigurðsson, Adam Baker, Arnar Pálsson, Gísli Másson, Daníel F. Guðbjartsson, Kristinn P. Magnússon, Karl Andersen, Allan I. Levey, Valgerdur M. Backman, Sigurborg Matthiasdottir, Þorbjörg Jónsdóttir, Stefan Palsson, H Einarsdottir, Steinunn Gunnarsdottir, Arnaldur Gylfason, Viola Vaccarino, W. Craig Hooper, Muredach P. Reilly, Christopher B. Granger, Harland Austin, Daniel J. Rader, Svati H. Shah, Arshed A. Quyyumi, Jeffrey R. Gulcher, Guðmundur Þorgeirsson, Unnur Þorsteinsdóttir, Augustine Kong, Kāri Stefánsson
Genetic mechanisms of critical illness in COVID-19
The GenOMICC Investigators, Erola Pairo‐Castineira, The ISARIC4C Investigators, The COVID-19 Human Genetics Initiative, 23andMe Investigators, BRACOVID Investigators, Gen-COVID Investigators, Sara Clohisey, Lucija Klarić, Andrew D. Bretherick, Konrad Rawlik, Dorota Pasko, Susan Walker, Nick Parkinson, Max Head Fourman, Clark D Russell, James Furniss, Anne Richmond, Viktoria‐Eleni Gountouna, Nicola Wrobel, David A Harrison, Bo Wang, Yang Wu, Alison Meynert, Fiona Griffiths, Wilna Oosthuyzen, Athanasios Kousathanas, Loukas Moutsianas, Zhijian Yang, Ranran Zhai, Chenqing Zheng, Graeme R. Grimes, Rupert Beale, Jonathan Millar, Barbara Shih, Seán Keating, Marie Zechner, Chris Haley, David J. Porteous, Caroline Hayward, Jian Yang, Julian C. Knight, Charlotte Summers, Manu Shankar‐Hari, Paul Klenerman, Lance Turtle, Antonia Ho, Shona C. Moore, Charles Hinds, Peter Horby, Alistair Nichol, David M. Maslove, Lowell Ling, Danny McAuley, Hugh Montgomery, Timothy Walsh, Alexandre C. Pereira, Alessandra Renieri, Xia Shen, Chris P. Ponting, Angie Fawkes, Albert Tenesa, Mark J. Caulfield, Richard H. Scott, Kathy Rowan, Lee Murphy, Peter Openshaw, Malcolm G. Semple, Andrew Law, Véronique Vitart, James F. Wilson, J. Kenneth Baillie, J. Kenneth Baillie
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su, Lei Dong, Yangchan Li, Min Gao, Li Han, Mark Wunderlich, Xiaolan Deng, Hongzhi Li, Yue Huang, Lei Gao, Chenying Li, Zhicong Zhao, Sean Robinson, Brandon Tan, Ying Qing, Xi Qin, Emily Prince, Jun Xie, Hanjun Qin, Wei Li, Chao Shen, Jie Sun, Prakash Kulkarni, Hengyou Weng, Huilin Huang, Zhenhua Chen, Bin Zhang, Xiwei Wu, Mark Olsen, Markus Müschen, Guido Marcucci, Ravi Salgia, Ling Li, Amir T. Fathi, Zejuan Li, James C. Mulloy, Minjie Wei, David Horne, Jianjun Chen
MEG3 noncoding RNA: a tumor suppressor
Yunli Zhou, Xun Zhang, Anne Klibanski
WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
Yunhao Chen, Chuanhui Peng, Junru Chen, Diyu Chen, Beng Yang, Bin He, Wendi Hu, Yanpeng Zhang, Hua Liu, Longfei Dai, Haiyang Xie, Lin Zhou, Jian Wu, Shusen Zheng
Where is RNA modifications and cancer research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on RNA modifications and cancer is open access?
ScholarIQopen access share
93%OPEN ACCESS